Google's AI video tool, Veo, offers a compelling alternative to OpenAI's Sora for creating healthcare advertising videos. While both tools demonstrate impressive capabilities, Veo 3.1 stands out for its enhanced realism and narrative control. MM+M's testing revealed that Veo 3.1 can produce highly realistic videos, often indistinguishable from those created by human actors. This level of realism is a significant advantage over Sora, where AI humans sometimes appear to have a 'halo' effect, detracting from the overall visual quality.
However, the potential for misuse is a concern. MM+M's experiment with generating a video promoting the false claim that acetaminophen causes autism highlights the importance of safety measures. Google's Veo employs 'safety code filters' to prevent harmful content, but these safeguards are not infallible. The tool rejected prompts involving public figures, but it still generated a misleading video, underscoring the need for vigilance in content creation.
The question arises: how should marketers approach these powerful AI tools? While Veo and Sora can generate healthcare messaging, there are valid reservations about their use. Adam Daley, VP of Social at CG Life, warns against replacing creative teams with AI, citing the potential loss of patient stories and the risk of damaging the trust built within communities. He emphasizes the value of real voices and actors, especially in sensitive healthcare campaigns.
The industry must navigate this new landscape carefully. As AI continues to evolve, marketers must consider the ethical implications and the potential impact on their audiences. The challenge is to harness the power of AI while maintaining authenticity and trust. The future of healthcare advertising may involve a blend of AI-generated content and human creativity, but the key lies in striking the right balance.
